SUMITOMO DAINIPPON PHARMA ONCOLOGY

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark SUMITOMO DAINIPPON PHARMA ONCOLOGY was filed as Word mark on 07/07/2020 at the World Intellectual Property Organization.

Trademark Details Last update: November 15, 2022

Trademark form Word mark
File reference 1554942
Countries Canada European Community United Kingdom United States of America (USA)
Base trademark JP No. 2020-046529, April 27, 2020
Application date July 7, 2020
Expiration date July 7, 2030

Trademark owner

6-8, Doshomachi 2-chome,
Chuo-ku, Osaka-shi
JP

Trademark representatives

Nakanoshima Festival Tower West, 2-4, Nakanoshima 3-chome, JP

goods and services

05 Pharmaceutical preparations; antitumor drugs; pharmaceutical preparations for the diagnosis, prevention and treatment of cancer; biological preparations for the treatment of cancer
42 Testing, inspection or research of pharmaceuticals; testing, inspection or research of pharmaceuticals for the diagnosis, prevention and treatment of cancer
44 Providing medical information; providing information in the field of cancer prevention, screening, diagnosis and treatment; health care services for treating cancer

Trademark history

Date Document number Area Entry
November 8, 2022 2022/46 Gaz CA Rejection
January 26, 2022 2022/5 Gaz CA Rejection
September 23, 2021 2021/38 Gaz US RAW: Rule 18ter(2)(i) GP following a provisional refusal
April 13, 2021 2021/15 Gaz GB Rejection
March 4, 2021 2021/10 Gaz EM Rejection
November 17, 2020 2020/47 Gaz US Rejection
July 7, 2020 2020/40 Gaz JP Registration

ID: 141554942